Staphylococcus aureus produces exotoxins of the epidermal cell differentiation inhibitor (EDIN) family that ADP-ribosylate and inactivate Rho GTPases. The prevalence of genes encoding EDIN in clinical and nasal isolates of S. aureus was investigated. Of the 196 clinical S. aureus isolates tested, 15 (7.8%) were positive for 1 edin gene, whereas of 81 nasal isolates tested, only 3 (3.7%) were edin positive. Of the total 18 edin-positive isolates, 16 (90%) carried edin-B and 2 (10%) carried edin-C, but none was positive for edin-A. All edin-positive strains could produce the respective EDIN protein. Pulsed-field gel electrophoresis analysis suggested that the edin-B-positive S. aureus isolates are derived from one clone, and the edin-C-positive isolates are derived from another clone. Given that toxins acting on Rho GTPases are considered to be important for bacterial virulence, the EDIN toxins of S. aureus should receive more attention in future studies.
the small GTPases RhoA and -B in target cells [7] . EDIN-B (termed C3Stau by Wilde et al. [6] ) shows 78% identity to EDIN-A and was reported to ADP-ribosylate RhoE, in addition to RhoA [6] . The most recently discovered EDIN isoform, EDIN-C, displays 66% and 72% identity to EDIN-A and -B, respectively (T.Y. and M.S., unpublished data).
Rho GTPases are central regulators of the eukaryotic actin cytoskeleton, and their inactivation by toxins and modulins of virulent bacteria has been shown to block important immune cell functions, such as chemotaxis, phagocytosis, and oxidative burst [8] . It is further well accepted that, through inactivation of Rho GTPases, toxins A and B of C. difficile cause pseudomembranous colitis [8] .
Despite their presumed importance in S. aureus virulence, the EDIN toxins of S. aureus have received no attention in clinical or epidemiologic studies. We tested the prevalence of genes encoding EDIN in S. aureus isolates from infection sites and nasal carriages.
Materials and Methods
S. aureus strains. Nasal isolates were collected from healthy students (21-43 years old) between November 1999 and November 2000. The clinical isolates of S. aureus were from a variety of infection sites (the eye and ear, tonsils, wounds, skin ulcers, arthritic joints, and blood) and pneumonia infections of patients (10-65 years old) hospitalized in Munich between November 1999 and November 2000. All isolates were positive for catalase, clumping factor, and DNase and carried the S. aureus-specific nuc gene, as determined by polymerase chain reaction (PCR) [9] .
PCR and sequencing. Genomic DNA of S. aureus was subjected to PCR, using the following primers and conditions: sense, 5 -ACTG- , 30 s at 50ЊC, and 2 min at 72ЊC, followed by an elongation period of 7 min at 72ЊC. PCR amplificates were purified, using a PCR purification kit (Qiagen), were sequenced, and were compared with the sequences of edin-A (accession no. M 63917), edin-B/C3Stau (accession no. AJ 277173), or edin-C (accession no. AP 003088).
Western blot. S. aureus-secreted proteins were subjected to 12% SDS-PAGE, followed by electroblotting onto polyvinylene difluoride membrane. EDIN proteins were detected by use of anti-EDIN-A (1:30,000) or anti-EDIN-C (1:10,000) antiserum, which was raised in rabbits against purified EDIN-A or EDIN-C, respectively [10] , and horseradish peroxidase-labeled donkey antirabbit antibody (1:7500; Amersham). Membranes were developed with enhanced chemiluminescence reagent (Amersham) and were exposed to X-ray films (Kodak).
Pulsed-field gel electrophoresis (PFGE).
PFGE of SmaIdigested S. aureus DNA was done according to standard protocols, using a CHEF-DR-II (Bio-Rad) apparatus. Agarose gels were stained with ethidium bromide and were photographed.
Southern blotting. Southern blotting hybridization was done as described elsewhere [11] . Interpretation of DNA fragment profiles for determination of the relatedness of the edin-positive isolates followed published guidelines [12] .
Results
Distribution of edin genes within clinical and nasal isolates of S. aureus. We first designed a PCR primer pair, to amplify a 531-bp DNA fragment within the coding region of edin-A [5] (see Materials and Methods for details). PCR was then used to check for the presence of edin in 196 S. aureus strains isolated from various infection sites of hospitalized patients and in 81 S. aureus strains isolated from the nose of healthy, asymptomatic carriers. Of the 196 clinical S. aureus isolates, 15 (7.8%) were edin positive, whereas of the 81 nasal samples, only 3 (3.7%) were edin positive. Sequencing of the respective PCR products revealed that 13 of the 15 edin-positive clinical isolates contained edin-B, and the remaining 2 contained edin-C. All 3 of the edin-positive isolates from nasal carriers contained edin-B (table 1). As demonstrated in table 2, the isolation sites of the edin-positive strains reflect the whole spectrum of infections normally associated with S. aureus. By performing immunoblots, using antibodies against full-length EDIN-A (which cross-react with EDIN-B) or EDIN-C, we confirmed that the 16 edin-B-positive and the 2 edin-Cpositive S. aureus strains produced the corresponding EDIN proteins (A.C. and M.A., data not shown).
Molecular relationships among edin-positive S. aureus strains. To test the relationships among the edin-positive S. aureus isolates, we subjected their SmaI-digested DNA to PFGE. The results of these experiments are shown in figure 1A and can be summarized as follows: (1) 14 of the 15 edin-B-positive isolates are closely related, as indicated by the fact that their DNA fragment profiles differ by only 0-4 bands ( figure 1A, lanes 1  and 3-15) ; (2) 1 edin-B-positive isolate exhibits 17 different DNA fragments in PFGE, unlike the other edin-B-positive isolates, indicating that it is unrelated to these isolates (figure 1A, lane 2); (3) the 2 edin-C-positive isolates differ from each other by only 1 fragment, suggesting that they are closely related ( figure 1A, lanes 16 and 17) ; and (4) the DNA profile of the edin-C-positive strains differs markedly from the profile of the edin-B-positive strains ( figure 1A, lanes 16 and 17) .
To localize edin-B and edin-C on the S. aureus genome, we blotted the SmaI-digested DNA onto nylon membranes and incubated it with peroxidase-labeled edin-B or edin-C DNA probes. The edin-B probe hybridized with a DNA fragment of ∼150 kb in all edin-B-positive strains except for the one clone that showed a distinct restriction fragment pattern, in which the probe hybridized to a slightly larger fragment ( figure 1B,  lanes 1 and 3-15 and lane 2; see filled arrowhead). The edin-B probe did not hybridize with DNA of the 2 edin-C-positive strains ( figure 1B, lanes 16 and 17) . A comparison of the ethidium bromide-stained agarose gel and the Southern blot revealed that the edin-B-reactive bands comigrate with DNA fragments obtained by the SmaI digestion of the S. aureus DNA ( figure 1A and 1B, lanes 1-15; see filled arrowheads) . By comparison, the edin-C probe hybridized to a high-molecular-mass band of ∼450 kb in the edin-C-positive strains, at which position there was no detectable DNA fragment ( figure 1C, lanes  16 and 17; see open arrowheads) .
Discussion
Within the last 10 years, it has become clear that bacterial toxins acting on Rho GTPases are important virulence factors of a wide variety of pathogenic bacteria [8] . The EDIN toxins of S. aureus were shown to ADP-ribosylate the Rho GTPases RhoA, -B, and -E in eukaryotic cells [6, 7] . We show here that a fraction of pathogenic S. aureus strains can produce 1 out of у3 different EDIN isoforms, which we call EDIN-A, EDIN-B (C3Stau), and EDIN-C, according to their publication sequence (T.Y. and M.S., unpublished data; [5, 6] ) . We also found that genes encoding EDIN have a higher prevalence (7.8%) in S. aureus strains isolated from infection sites than in strains isolated from nasal carriers (3.7%). The prevalence of edin genes is thus very similar to that of the exfoliative toxins A and B [2] .
Of the edin-positive S. aureus strains identified by us, 90% produce EDIN-B and 10% produce EDIN-C. Preliminary data indicate that in Japanese S. aureus isolates, the predominant isoform is edin-C, followed by edin-A and edin-B (T.Y. and M.S., unpublished data). This indicates that the EDIN isoforms, like the 2 isoforms of the exfoliative toxins, show a distinct geographic distribution [2] . PFGE analysis demonstrated that all but one of the S. aureus strains carrying edin-B are closely related to each other, and the 2 edin-C-positive strains are similarly related; however, there is no relationship between these 2 groups of strains. Southern blot analysis suggested that edin-B is chromosomally located, whereas edin-C may be located on a plasmid. Of interest, edin-A is also present on a large plasmid in S. aureus (T.Y. and M.S., unpublished data). Furthermore, the original EDIN-A-producing strain E-1 shows a DNA fragment profile highly similar to the profile of our 2 EDIN-C-producing strains (A.C. and M.A., data not shown), suggesting a close relationship of the EDIN-A-and EDIN-C-positive strains.
There are major questions to be answered before EDIN can be considered to be an important virulence factor of S. aureus. For instance, it needs to be determined whether specific S. aureus infections, such as those of the skin, are strongly associated with EDIN production. Investigation of EDIN expression and production in cell culture experiments and animal models will further elucidate the role of these toxins in the pathogenicity of S. aureus.
